The discussion touched upon
the commercialization of academic science, conflicts in biomedical research, and gene patents.
Not exact matches
Chris is on a number
of national and international committees, working groups and initiatives related to the
academic, clinical translation and
commercialization of cell and gene therapies including; Founder and CEO of the London Regenerative Medicine Network (LRMN), Founding Member of the UK - Israel Science Council, Scientific Advisory Board of the UK Cell and Gene Therapy Catapult, Strategic Advisory Board of the Canadian Centre for the Commercialization of Regenerative Medicine (CCRM), and Scientific Advisory Board of the Canadian S
commercialization of cell and gene therapies including; Founder and CEO
of the London Regenerative Medicine Network (LRMN), Founding Member
of the UK - Israel
Science Council, Scientific Advisory Board
of the UK Cell and Gene Therapy Catapult, Strategic Advisory Board
of the Canadian Centre for the
Commercialization of Regenerative Medicine (CCRM), and Scientific Advisory Board of the Canadian S
Commercialization of Regenerative Medicine (CCRM), and Scientific Advisory Board
of the Canadian Stem Cell Network.
And David Brindley is founder and
academic director
of CASMI's Translational Stem Cell Consortium, senior healthcare translation research fellow in the medical
sciences division's department
of paediatrics at the University
of Oxford, Cooksey - Saïd fellow in healthcare translation at the University
of Oxford's Saïd Business School, honorary senior research associate at the University College London School
of Pharmacy's Centre for Behavioral Medicine (London, UK), a research fellow in cell therapy
commercialization at the Harvard Stem Cell Institute (Cambridge, MA), and regenerative medicine regulation and risk management lead at the USCF - Stanford Center
of Excellence in Regulatory
Science and Innovation (CERSI) in Stanford, CA.
He studies the
commercialization of academic research, countercultural
science and technology, and the longue durée
of responsible research and innovation.